RxDoctor Payments DataLook up a doctor →

Gautam Yagnik, MD

Sports Medicine · Miami, FLNPI 1609936475

Payments from drug & device makers

$457,619in general payments, 2019–2025

Across 481 payments — averaging $951.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$453K
  • Southern Edge Orthopaedics, Inc.$2K
  • Smith+Nephew$498
  • Arthrosurface Incorporated$399
  • Anika Therapeutics, Inc.$352
  • Vericel Corporation$297
  • plus $945 from 10 others
$33in research payments, 2019–2025

Across 1 payment — averaging $33.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lifenet Health$33

What the payments were for

  • Royalty or licence$135,72631%
  • Consulting fees$176,29140%
  • Speaking & faculty fees$111,29125%
  • Travel & lodging$6,6832%
  • Food & beverage$8,0372%
  • Education$2,1980%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$457,619 in reported general payments places this provider in the 95th percentile of 402 sports medicine providers in Florida.

See all sports medicine providers in Florida

Medicare billing

Part B allowed, 2024
$79,303
Medicare patients
147
Services billed
2,500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium16$332
Celecoxib16$151
Meloxicam33$118

Paid to pharmacies, not to this prescriber.

Other sports medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →